1Assistant professor of REI, JSFG CME head, Faculty of Medicine, The Hashemite university , Zarqa, Jordan
2JSFG president, MRCOG, Lecturer at Faculty of Medicine, Al.Balqa university,Jordan
3Senior consultant of REI, Royal Medical Services, Jordan
4JFSG Vice president, senior consultant of urology and andrology, Jordan
5Biological science Department, University of Jordan, Jordan
6MSc clinical embryology, CME JSFG, Jordan
7Consultant of OB & Gyn, Financial committee of JSFG, Jordan
*Corresponding author:Firas Al Rshoud, Assistant professor of REI, JSFG CME head, Faculty of Medicine, The Hashemite university , Zarqa, Jordan
Submission: October 01, 2020Published: October 07, 2020
Volume4 Issue2 October, 2020
Objective: This JSFG guidance comes in response to the coronavirus (COVID-19) global pandemic crisis and to the need of a clear information for provision of ART and Infertility treatments in Jordan aiming to protect both the patients and the health care workers [1]. By the end of September 2020, the risk of COVID-19 infection is increasing dramatically in Jordan (we are close from 2000 case/day), the normal daily Work should be modified to adapting a new life taking in consideration the following:
1. The risk of COVID-19 infection is the highest in Jordan than any other time.
2. The COVID-19 virus is a new challenge to staff and health care workers
3. Evidence is very limited evidence at many aspects, especially a curative treatment.
4. Adherence to safety measurements like physical distancing and wearing a face mask is very important in decreasing the risk of virus transmission.
Conclusion: We hope after the release of the JSFG guidance on Recommencing ART and Infertility Treatments our colleagues in the ART field will have a clear information that makes the work safer for both the staff and the patients during the pandemic of COVID-19.
Keywords: COVID-19; ART and Safety